BioPharma Dive Mar 6, 2026 Pfizer nabs first obesity approval; Alnylam, Tenaya search for heart drugs
BioPharma Dive Mar 4, 2026 FDA again targets GLP-1 compounders; Intellia to restart heart disease trial